Explore the future of organ transplants and how biotech innovations like 3D bioprinting and stem cells can solve the organ ...

A new international study published in the journal Gastroenterology has shown that the approach first developed in University ...

Background Treatment strategies for Crohn’s disease (CD) suppress diverse inflammatory pathways but many patients remain ...

Induced pluripotent stem cells (iPSCs), which greatly circumvent the ethical issue of human embryonic stem cells (ESCs), can be induced to differentiate to dopaminergic (DA) neurons, and hence be used ...

When investigators design a clinical trial of stem cell therapy for heart disease, they have to consider that the imaging technique to be selected should measure all surrogate parameters of death ...

These differences could be due, at least in part, to the diverse designs of experiments, such as the dose, route of administration, initial time of stem cells therapy, severity of disease ...

mucosa.de Objective The genetic basis of inflammatory bowel disease (IBD) is incompletely understood ... apoptosis, and natural killer T cell development. Private variants in XIAP are commonly ...

The aim of this case report is to evaluate the efficacy of mesenchymal stem cell (MSC) therapy in the treatment of small joint osteoarthritis (OA). Acromio-clavicular (AC) joint OA is an ...

For years, the Food and Drug Administration has taken up arms against clinics hawking unproven and ineffective stem cell treatments to desperate patients looking for cures of intractable diseases ...

U.K. Not yet recruiting Prochymal Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-Severe Crohn's Disease Crohn's disease BM-derived allogeneic MSC (Prochymal) OsirisTherapeutics ...

For years, the Food and Drug Administration has taken up arms against clinics hawking unproven and ineffective stem cell ... disease, knee problems and other orthopedic conditions; lupus, Crohn ...